The entire top management staff of LINC Scientific Imaging hasleft Mobile Technology (MTI), the world's largest mobile imagingfirm. LINC Scientific Imaging was sold by its parent company,LINC, to MTI of Los Angeles earlier this year (SCAN 12/12/90).
The entire top management staff of LINC Scientific Imaging hasleft Mobile Technology (MTI), the world's largest mobile imagingfirm. LINC Scientific Imaging was sold by its parent company,LINC, to MTI of Los Angeles earlier this year (SCAN 12/12/90).
The mobile executives opted to stay together and form a newimaging services company, Signal Medical Services of Farmington,CT, said Barry E. O'Brien, president and CEO. LSI was also basedin Farmington.
The executives have non-compete agreements with MTI that preventthem from soliciting business from former LSI customers untilMarch of next year. They are brewing big plans, however, mostlyin fixed-site rather than mobile imaging.
Signal is negotiating with a major financial institution thathas raised nearly $60 million to develop magnetic resonance imagingcenters, O'Brien said. His company would like to manage thoseMRI centers.
The imaging services firm was incorporated in April. All ofthe top LSI executives have maintained their former positionsin the new company. In addition to O'Brien, these include:
While Signal's strategic plan includes mobile imaging, thecompany expects to place primary emphasis on fixed-site MRI servicesin partnership with hospitals or on a fee-per-scan basis. Trendsin the imaging market spell sluggish opportunities in mobile services,O'Brien said.
"It is our belief that the mission of mobile MRI has beenlargely fulfilled. We see equipment today costing 25% to 30% ofwhat it cost just three years ago. That is bringing a lot of newplayers into fixed-site imaging," he said.
Signal will venture into mobile routes only when it is fairlycertain of the potential for longevity and sufficient volume,he said. The firm is actively investigating possibilities in anothermobile imaging modality, however. Signal is talking with a positronemission tomography vendor and a cyclotron manufacturer aboutcollaborating in the provision of mobile PET services.
"We believe that, because of its high cost and relativelynarrow band of clinical applications, PET is an ideal technologyfor mobile services," O'Brien said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.